| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/05/2000 | CN1240482A Methods for producing polypeptides in surfaction mutants of bacillus cells |
| 01/05/2000 | CN1240481A Infections clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 01/05/2000 | CN1240479A Truncated soluble tumor necrosis factor type-I and type-II receptors |
| 01/05/2000 | CN1240359A Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 01/04/2000 | US6011198 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 01/04/2000 | US6011175 Inhibition of farnesyltransferase |
| 01/04/2000 | US6011147 Trichoderma |
| 01/04/2000 | US6011146 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant |
| 01/04/2000 | US6011137 Fusion proteins |
| 01/04/2000 | US6011068 Carbocyclic-alkyl secondary amines |
| 01/04/2000 | US6011020 Nucleic acid ligand complexes |
| 01/04/2000 | US6011018 Regulated transcription of targeted genes and other biological events |
| 01/04/2000 | US6011014 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis |
| 01/04/2000 | US6011013 Contraceptive compositions and methods |
| 01/04/2000 | US6011012 Cysteine proteinase inhibitors |
| 01/04/2000 | US6011007 Acylated insulin |
| 01/04/2000 | US6011005 Administering an effective amount of a fetuin polypeptide. |
| 01/04/2000 | US6011003 Vascular endothelial growth factor (vegf) inhibitors |
| 01/04/2000 | US6011002 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/04/2000 | US6010999 Stabilization of fibroblast growth factors by modification of cysteine residues |
| 01/04/2000 | US6010913 Isolated human tau peptide |
| 01/04/2000 | US6010908 Gene therapy by small fragment homologous replacement |
| 01/04/2000 | US6010901 Vectors |
| 01/04/2000 | US6010897 Expression of signal-peptide-free staphylokinases |
| 01/04/2000 | US6010895 Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat |
| 01/04/2000 | US6010886 Receptor for oncostatin M |
| 01/04/2000 | US6010885 Expression of heterologous polypeptides in halobacteria |
| 01/04/2000 | US6010883 Recombinant fusion proteins |
| 01/04/2000 | US6010882 Production of biologically active recombinant insulin-like growth factor II polypeptides |
| 01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
| 01/04/2000 | US6010880 Inhibitors of human plasmin derived from the kunitz domains |
| 01/04/2000 | US6010879 Polynucleotides encoding human mitochondrial chaperone proteins |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| 01/04/2000 | US6010876 Clavanins |
| 01/04/2000 | US6010875 Expressions plasmids containing the deo promoter, and bacterial hosts containing the plasmids |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
| 01/04/2000 | US6010871 Modification of peptide and protein |
| 01/04/2000 | US6010866 Determination of analytes in biological fluids in the presence of substances interfering with assays therefor |
| 01/04/2000 | US6010865 Process for detecting a variant CD44 gene product |
| 01/04/2000 | US6010864 Peptides representing epitopic sites on r-IFN-β,antibodies thereto, and uses thereof |
| 01/04/2000 | US6010862 Methods of detecting collagen type III degradation in vivo |
| 01/04/2000 | US6010860 Method for site-specific integration of nucleic acids and related products |
| 01/04/2000 | US6010859 RAB protein |
| 01/04/2000 | US6010858 Method for expression cloning of gene encoding protein kinase substrate protein |
| 01/04/2000 | US6010856 Assay systems and methods for measuring P38 map kinase, and modulators thereof |
| 01/04/2000 | US6010855 Desaturase antigen of mycobacterium tuberculosis |
| 01/04/2000 | US6010854 Autoantibodies to neurotransmitter receptors |
| 01/04/2000 | US6010853 Siva genes, novel genes involved in CD27-mediated apoptosis |
| 01/04/2000 | US6010849 Sequence-directed DNA binding molecules compositions and methods |
| 01/04/2000 | US6010848 Screening methods using an atpase protein from hepatitis C virus |
| 01/04/2000 | US6010845 Leukocyte adhesion assay |
| 01/04/2000 | US6010844 Methods of preparing and recovering proteins |
| 01/04/2000 | US6010705 Attenuated, invasive vaccines against fish pathogens |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | US6010703 Genetic engineering; inserting gene into gene encoding thymidine kinase |
| 01/04/2000 | US6010700 Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
| 01/04/2000 | US6010698 Adsorption by cation exchange resin |
| 01/04/2000 | US6010694 Fibrillin 1 gene comprising duplication mutation and compositions and kits using the same |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | US6010679 Transition metal radionucleolide; contrast agents for diagnosing cardiovascular disorders, cancer |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 01/04/2000 | CA2093145C Substantially pure interleukin-9 receptor and uses thereof |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA2026610C Chemically modified allergens and process for the preparation thereof |
| 01/04/2000 | CA2005478C Method for solubilization and naturation of somatotropin |
| 01/04/2000 | CA1340869C T cell activation markers |
| 01/04/2000 | CA1340867C Expression plasmids for improved production of heterologus protein in bacteria |
| 01/03/2000 | CA2242116A1 Method for genetic engineering of disease resistance using the dr206 class of proteins |
| 12/30/1999 | DE19829005A1 A method to transport molecular substances inside eukaryotic cell |
| 12/30/1999 | DE19828097A1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| 12/30/1999 | DE19827837A1 Preparation of conjugates for predictive testing, diagnosis, prophylaxis or therapy of immunological sensitization to chemicals |
| 12/30/1999 | CA2276564A1 Modified c1 esterase inhibitor for blocking the infectiousness of hiv |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067426A1 Absorptive hypercalciuria locus on human chromosome 1 |
| 12/29/1999 | WO1999067415A1 Novel molecules of the t110-related protein family and uses thereof |
| 12/29/1999 | WO1999067407A2 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 12/29/1999 | WO1999067405A2 Leafy cotyledon1 genes and their uses |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067394A1 Vector expressing the full-length gene of rna virus and use thereof |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067391A1 Origin of replication and methods of use |
| 12/29/1999 | WO1999067390A1 IMPROVED PROCESS FOR THE PRODUCTION OF β-LACTAMS |
| 12/29/1999 | WO1999067387A2 Novel mp-7 protein and nucleic acid molecules and uses therefor |
| 12/29/1999 | WO1999067386A2 Differentially expressed genes in pancreatic cancer and displasia |
| 12/29/1999 | WO1999067385A1 Novel msp-5 protein and nucleic acid molecules and uses therefor |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067383A1 Novel g protein-coupled receptor protein, dna and use thereof |
| 12/29/1999 | WO1999067382A2 Angiopoietin-like growth factor sequences |
| 12/29/1999 | WO1999067377A1 Human arf-related proteins |
| 12/29/1999 | WO1999067375A2 Screening system |
| 12/29/1999 | WO1999067373A2 Invertebrate intestinal mucins, cdnas, antibodies and their use |
| 12/29/1999 | WO1999067369A1 Cell cycle regulatory factor |
| 12/29/1999 | WO1999067366A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein |
| 12/29/1999 | WO1999067361A1 Allelic series of genomic modifications in cells |
| 12/29/1999 | WO1999067360A2 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067356A2 Propionibacterium vector |